Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey

Abstract Background Basal cell carcinoma is the most common skin cancer worldwide. Treatment options include both surgical and topical modalities. Although risk of metastasis is low, basal cell carcinoma can be invasive and infiltrate important underlying structures such as bone or cartilage. While...

Full description

Bibliographic Details
Main Authors: Daniel I. Schlessinger, Sanjana Iyengar, Arianna F. Yanes, Jake M. Lazaroff, Victoria Godinez-Puig, Brian R. Chen, Anastasia O. Kurta, Jill K. Henley, Sarah G. Chiren, Karina C. Furlan, Jochen Schmitt, Stefanie Deckert, Emily Poon, Joseph F. Sobanko, Todd V. Cartee, Murad Alam, Ian A. Maher
Format: Article
Language:English
Published: BMC 2017-10-01
Series:Trials
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13063-017-2244-5